InvestSMART

Neuren Pharmaceuticals Limited (ASX: NEU) - Announcements

Current share price for NEU : $17.540 0.85 (5.09%)+

ASX company news and announcements for Neuren Pharmaceuticals Limited (NEU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neuren Pharmaceuticals Limited (NEU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neuren Pharmaceuticals Limited (NEU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neuren Pharmaceuticals Limited (NEU)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$2,224 Notification of cessation of securities - NEU 25 Jun 2025 5:26PM $12.540 $17.540 risen by 39.87%
$2,224 Update - Notification of buy-back - NEU 16 Jun 2025 9:28AM $13.100 $17.540 risen by 33.89%
$2,224 Update - Notification of buy-back - NEU 16 Jun 2025 9:07AM $13.100 $17.540 risen by 33.89%
$2,224 Update - Notification of buy-back - NEU 13 Jun 2025 8:26AM $13.900 $17.540 risen by 26.19%
$2,224 Update - Notification of buy-back - NEU 12 Jun 2025 7:45AM $13.830 $17.540 risen by 26.83%
$2,224 Update - Notification of buy-back - NEU 11 Jun 2025 8:07AM $13.990 $17.540 risen by 25.38%
$2,224 Update - Notification of buy-back - NEU 10 Jun 2025 8:33AM $13.760 $17.540 risen by 27.47%
$2,224 Update - Notification of buy-back - NEU 6 Jun 2025 9:13AM $13.900 $17.540 risen by 26.19%
$2,224 Update - Notification of buy-back - NEU 5 Jun 2025 7:50AM $13.900 $17.540 risen by 26.19%
$2,224 Notification of cessation of securities - NEU 4 Jun 2025 4:30PM $13.900 $17.540 risen by 26.19%
$2,224 Update - Notification of buy-back - NEU 4 Jun 2025 8:30AM $13.710 $17.540 risen by 27.94%
$2,224 Update - Notification of buy-back - NEU 3 Jun 2025 8:38AM $13.570 $17.540 risen by 29.26%
$2,224 Update - Notification of buy-back - NEU 2 Jun 2025 8:51AM $13.880 $17.540 risen by 26.37%
$2,224 Update - Notification of buy-back - NEU 30 May 2025 8:41AM $14.130 $17.540 risen by 24.13%
$2,224 Update - Notification of buy-back - NEU 29 May 2025 8:00AM $13.810 $17.540 risen by 27.01%
$2,224 Update - Notification of buy-back - NEU 28 May 2025 7:31AM $14.050 $17.540 risen by 24.84%
$2,224 Results of Meeting 27 May 2025 12:17PM $13.720 $17.540 risen by 27.84%
$2,224 AGM Chair Address & CEO Presentation 27 May 2025 10:19AM $13.800 $17.540 risen by 27.10%
$2,224 Update - Notification of buy-back - NEU 27 May 2025 8:41AM $13.450 $17.540 risen by 30.41%
$2,224 Update - Notification of buy-back - NEU 26 May 2025 9:11AM $12.870 $17.540 risen by 36.29%
$2,224 Notification regarding unquoted securities - NEU 23 May 2025 5:15PM $12.870 $17.540 risen by 36.29%
$2,224 Approval of long-term equity incentive 23 May 2025 11:51AM $12.785 $17.540 risen by 37.19%
$2,224 Update - Notification of buy-back - NEU 23 May 2025 8:43AM $12.840 $17.540 risen by 36.60%
$2,224 Update - Notification of buy-back - NEU 22 May 2025 8:21AM $12.920 $17.540 risen by 35.76%
$2,224 Update - Notification of buy-back - NEU 21 May 2025 7:31AM $12.820 $17.540 risen by 36.82%

76 - 100 of 821 results

Page 4 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.